Invasive NSTEMI Strategy Shows No Benefit in Frail Patients
-
By
-
Kathryn Wighton
-
May 6, 2026
-
4 min
By
Kathryn Wighton
May 6, 2026
by Zhenrun Zhan, Ke Zheng, Yalong Tu, Chao Lan, Lifeng Zheng
July 21, 2026
A nationwide German claims analysis found lower initiation of guideline-recommended sodium-glucose cotransporter-2 inhibitors among women and patients living in lower-income municipalities.
July 17, 2026